Clinical trial
A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies
NCT00038025 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00038025 |
|---|---|
| Title | A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies |
| Official title | A Phase II Study of Deoxycoformycin (DCF) in Lymphoid Malignancies |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma, Chronic Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | Deoxycoformycin (DCF) |
| Enrollment | 60 |
| Start date | Sep 6, 1994 |
| Primary completion | Nov 29, 2006 |
| Completion | Nov 29, 2006 |
| First posted | May 27, 2002 |
| Last update posted | Nov 16, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: